These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 11605815)

  • 1. Characteristics of patients with Burkholderia cepacia bacteremia.
    Huang CH; Jang TN; Liu CY; Fung CP; Yu KW; Wong WW
    J Microbiol Immunol Infect; 2001 Sep; 34(3):215-9. PubMed ID: 11605815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and outcomes of patients with Burkholderia cepacia bacteremia in an intensive care unit.
    Liao CH; Chang HT; Lai CC; Huang YT; Hsu MS; Liu CY; Yang CJ; Hsueh PR
    Diagn Microbiol Infect Dis; 2011 Jun; 70(2):260-6. PubMed ID: 21392926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes.
    Sligl W; Taylor G; Brindley PG
    Int J Infect Dis; 2006 Jul; 10(4):320-5. PubMed ID: 16460982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for mortality in patients with Burkholderia cepacia complex bacteraemia.
    Ku NS; Han SH; Kim CO; Baek JH; Jeong SJ; Jin SJ; Choi JY; Song YG; Kim JM
    Scand J Infect Dis; 2011 Oct; 43(10):792-7. PubMed ID: 21888567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkholderia cepacia bacteremia: a retrospective analysis of 70 episodes.
    Lu DC; Chang SC; Chen YC; Luh KT; Lee CY; Hsieh WC
    J Formos Med Assoc; 1997 Dec; 96(12):972-8. PubMed ID: 9444917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endemic burkholderia cepacia bacteraemia: clinical features and antimicrobial susceptibilities of isolates.
    Yu WL; Wang DY; Lin CW; Tsou MF
    Scand J Infect Dis; 1999; 31(3):293-8. PubMed ID: 10482060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia.
    Lin YC; Chen TL; Ju HL; Chen HS; Wang FD; Yu KW; Liu CY
    J Microbiol Immunol Infect; 2006 Feb; 39(1):67-72. PubMed ID: 16440126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacteremia caused by Stenotrophomonas maltophilia: a clinical-epidemiological study and resistance profile].
    Ubeda P; Salavert M; Giner S; Jarque I; López-Aldeguer J; Pérez-Bellés C; Gobernado M
    Rev Esp Quimioter; 1998 Sep; 11(3):205-15. PubMed ID: 9795306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burkholderia Sepsis in Children as a Hospital-Acquired Infection.
    Kim KY; Yong D; Lee K; Kim HS; Kim DS
    Yonsei Med J; 2016 Jan; 57(1):97-102. PubMed ID: 26632388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Burkholderia cepacia bacteremia: a prospective analysis of 33 episodes].
    Pinilla MI; Cobos-Trigueros N; Soriano Á; Martínez JA; Zboromyrska Y; Almela M; Mensa J
    Rev Esp Quimioter; 2011 Dec; 24(4):209-12. PubMed ID: 22173191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The isolation of Burkholderia cepacia in a hospital setting in Sri Lanka.
    Perera N; Palasuntheram C
    Ceylon Med J; 2000 Sep; 45(3):116-8. PubMed ID: 11192990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremia.
    Woods CW; Bressler AM; LiPuma JJ; Alexander BD; Clements DA; Weber DJ; Moore CM; Reller LB; Kaye KS
    Clin Infect Dis; 2004 May; 38(9):1243-50. PubMed ID: 15127335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital.
    Ye Y; Li JB; Ye DQ; Jiang ZJ
    Infection; 2006 Oct; 34(5):252-7. PubMed ID: 17033748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusobacterium bacteremia: clinical significance and outcomes.
    Su CP; Huang PY; Yang CC; Lee MH
    J Microbiol Immunol Infect; 2009 Aug; 42(4):336-42. PubMed ID: 19949758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nosocomial Burkholderia cepacia infections in a Turkish university hospital: a five-year surveillance.
    Dizbay M; Tunccan OG; Sezer BE; Aktas F; Arman D
    J Infect Dev Ctries; 2009 May; 3(4):273-7. PubMed ID: 19759490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of antimicrobial agents, alone and in combinations, against Burkholderia cepacia isolated from blood.
    Lu DC; Chang SC; Chen YC; Luh KT; Hsieh WC
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):187-91. PubMed ID: 9327247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burkholderia cepacia septicemia in a pediatric oncology patient: a pharmacotherapy challenge.
    Durham SH; Lee AE; Assanasen C
    Ann Pharmacother; 2012 Jun; 46(6):e16. PubMed ID: 22570430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A National Guard outbreak of Burkholderia cepacia infection and colonization secondary to intrinsic contamination of albuterol nebulization solution.
    Balkhy HH; Cunningham G; Francis C; Almuneef MA; Stevens G; Akkad N; Elgammal A; Alassiri A; Furukawa E; Chew FK; Sobh M; Daniel D; Poff G; Memish ZA
    Am J Infect Control; 2005 Apr; 33(3):182-8. PubMed ID: 15798674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance.
    Shih HI; Lee HC; Lee NY; Chang CM; Wu CJ; Wang LR; Ko NY; Ko WC
    J Microbiol Immunol Infect; 2005 Oct; 38(5):350-7. PubMed ID: 16211144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acinetobacter calcoaceticus-baumannii complex bacteremia: analysis of 82 cases.
    Lin SY; Wong WW; Fung CP; Liu CE; Liu CY
    J Microbiol Immunol Infect; 1998 Jun; 31(2):119-24. PubMed ID: 10596990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.